New Cochrane Library feature will help Information Specialists and systematic review authors produce trustworthy evidence. Cochrane has launched a new feature in CENTRAL, our database of reports of ...
For decades, J.D. Power’s research has been a key tool for savvy consumers trying to separate companies with high-quality products and world-class customer service from the other guys.
Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading on Wednesday, marking its biggest intraday drop since July 2023, even as the healthcare giant posted better-than-expected financials for Q4 ...
J&J said that about a third of adults will not respond to oral antidepressants alone. Sign up here to get The Results Are In with Dr. Sanjay Gupta every Friday from the CNN Health team.
Liz Giuffre does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
This table of contents is a navigational tool, processed from the headings within the legal text of Federal Register documents. This repetition of headings to form internal navigation links has no ...
The deal would help accelerate growth in J&J's drugs business after the company spun off its consumer health unit in 2023. It has made several transactions in the past few years to boost its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results